Japan· JP-3969004F4020
ボグリボース
A voglibose product containing ボグリボース, registered in Japan by Ｔ’ｓ製薬, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ボグリボース
- Manufacturer
- Ｔ’ｓ製薬
- Country
- Japan (JP)
- ATC code
- A10BF03
- ATC class
- Voglibose
- Defined daily dose
- 0.6 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A10BF03
Voglibose, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f1b9e328-0f1f-4b40-abf8-14e9415d67bb GET /v1/drugs/f1b9e328-0f1f-4b40-abf8-14e9415d67bb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "０．３ｍｇ１錠",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "3969004F4020",
"category": "内用薬",
"price_yen": 12.9,
"generic_name": "ボグリボース",
"product_name_jp": null,
"therapeutic_class": "3969",
"transitional_expiry": null
}See everything about voglibose.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.